8-K: Onconetix Stockholders Approve Key Proposals, Including Reverse Stock Split

Onconetix, Inc. announced that its stockholders approved all matters put forth at the 2026 Annual Meeting, including director election, a Series F PIPE issuance, a reverse stock split authorization, and auditor ratification.

Summary

• On November 10, 2026, Onconetix, Inc. held its annual meeting of stockholders where all proposed matters were approved.
• Key approvals include the election of Josh Epstein as a Class II director, the issuance of common stock upon conversion of Series F Preferred Stock from a private placement, and authorization for a reverse stock split.
• The company also ratified the appointment of Malone Bailey, LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026.
• The reverse stock split, with a ratio between 1-for-2 and 1-for-15, is to be determined by the Board and must be completed within one year of the meeting.
• Voting was based on 5,241,486 shares of Common Stock outstanding as of September 29, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as key proposals were approved, but the reverse stock split indicates potential underlying financial challenges.

Positives

• All five proposals presented at the annual meeting were approved by stockholders.
• Josh Epstein was elected to the Board of Directors for a three-year term.
• The issuance of common stock related to the Series F Preferred Stock private placement was approved, facilitating a prior transaction.
• The appointment of Malone Bailey, LLP as the independent auditor for fiscal year 2026 was ratified.

Negatives

• The authorization for a reverse stock split suggests the company may be facing challenges in maintaining its stock price above minimum exchange listing requirements.
• A significant number of broker non-votes were recorded for the Director Election Proposal, indicating a portion of shares were not voted by the beneficial owner's broker.

Risks

• The need for a reverse stock split could indicate underlying financial performance issues or a strategy to avoid delisting from the Nasdaq Stock Market.
• The Series F PIPE Proposal involved the issuance of up to 154,856,150 shares, which could lead to significant dilution for existing shareholders.
• The company sought approval to adjourn the meeting if necessary to solicit additional proxies, suggesting potential uncertainty in achieving sufficient votes for certain proposals.

Future Outlook

The company has authorized its Board of Directors to implement a reverse stock split within a range of 1-for-2 to 1-for-15, with the exact ratio to be determined, and must be completed within one year of the annual meeting.

Management Comments

• The company's Chief Executive Officer, David A. White, signed the report, indicating his authorization and oversight of the filing.

Industry Context

StockSavvy.ai notes that the approval of a reverse stock split is a common, albeit often concerning, action taken by companies, particularly those listed on major exchanges like Nasdaq, to increase their per-share stock price and meet minimum bid price requirements. The approval of a PIPE transaction and director election are standard corporate governance activities.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution from the Series F PIPE issuance and potential impact on share price and market perception due to the authorized reverse stock split.
• Board of Directors: Addition of Josh Epstein to the board, and empowered to execute a reverse stock split.
• Auditors: Malone Bailey, LLP confirmed as independent auditor for FY2026.

Next Steps

• The Board of Directors will determine the exact ratio for the reverse stock split (between 1-for-2 and 1-for-15).
• The reverse stock split must be completed no later than the one-year anniversary of the Annual Meeting.
• Malone Bailey, LLP will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

Key Dates

Recommendation

The approval of key proposals is positive, but the need for a reverse stock split and the potential dilution from the PIPE transaction introduce significant uncertainty. A hold recommendation allows for observation of the company's execution of the reverse stock split and its impact on financial health and market perception.

Keywords

Annual Meeting, Stockholder Approval, Reverse Stock Split, Director Election, PIPE Transaction, Auditor Ratification, Preferred Stock Conversion, Corporate Governance